The Journal of Immunology, Vol 153, Issue 11 5016-5025, Copyright © 1994 by American Association of Immunologists

ARTICLES

Chymase-directed serine protease inhibitor that reacts with a single 30- kDa granzyme and blocks NK-mediated cytotoxicity

SL Woodard, DS Jackson, AS Abuelyaman, JC Powers, U Winkler and D Hudig
Department of Microbiology, School of Medicine, University of Nevada, Reno 89557.

Cytotoxic NK and T lymphocytes kill virally infected cells within minutes without causing damage to themselves or bystander cells. One mechanism of killing involves exocytosis of granules containing serine proteases and perforin. Serine protease inhibitors block killing of target cells mediated by the cytotoxic lymphocytes. There are at least five different serine protease activities in cytolytic granules. Ten different serine protease sequences have been identified with the use of cDNA-specific clones. It is not known whether only one or several of these serine proteases are essential for cytolytic activity. In this study we show that an irreversible serine protease inhibitor, biotinyl- Aca-Aca-Phe-Leu-PheP(OPh)2, selectively inhibits a chymotrypsin-like (chymase) serine protease activity of rat RNK-16 granule extracts. Under the same conditions, only one 30-kDa (reduced) band was detected on protein blots. Furthermore, only one of three chymase peaks separated by hydrophobic interaction chromatography was inhibited. When this granzyme was inhibited, granule-mediated lysis of erythrocytes was diminished. NK cell killing was completely blocked when biotinyl-Aca- Aca-Phe-Leu-PheP(OPh)2 was added to cytotoxicity assays at 200 microM with rat splenocytes as effectors. By confocal fluorescence microscopy, we show that this inhibitor localizes to distinct regions within RNK-16 cells and rat NK cells. Inhibitor treatment of intact cells inactivated the chymase activity and reduced lysis found in their dense organelles. Together these data indicate that biotinyl-Aca-Aca-Phe-Leu-PheP(OPh)2 inhibits a granule chymase that is essential to cytolytic activity of NK cells.

This article has been cited by other articles:

				E. Fellows, S. Gil-Parrado, D. E. Jenne, and F. C. Kurschus Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program Blood, July 15, 2007; 110(2): 544 - 552. [Abstract] [Full Text] [PDF]

				M. D. Woolard, D. Hudig, L. Tabor, J. A. Ivey, and J. W. Simecka NK Cells in Gamma-Interferon-Deficient Mice Suppress Lung Innate Immunity against Mycoplasma spp. Infect. Immun., October 1, 2005; 73(10): 6742 - 6751. [Abstract] [Full Text] [PDF]

				M. Bots, I. G. M. Kolfschoten, S. A. Bres, M. T. G. A. Rademaker, G. M. de Roo, M. Kruse, K. L. M. C. Franken, M. Hahne, C. J. Froelich, C. J. M. Melief, et al. SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity Blood, February 1, 2005; 105(3): 1153 - 1161. [Abstract] [Full Text] [PDF]

				S. Mahrus, W. Kisiel, and C. S. Craik Granzyme M Is a Regulatory Protease That Inactivates Proteinase Inhibitor 9, an Endogenous Inhibitor of Granzyme B J. Biol. Chem., December 24, 2004; 279(52): 54275 - 54282. [Abstract] [Full Text] [PDF]

				S. L. Woodard, S. A. Fraser, U. Winkler, D. S. Jackson, C.-M. Kam, J. C. Powers, and D. Hudig Purification and Characterization of Lymphocyte Chymase I, a Granzyme Implicated in Perforin-Mediated Lysis J. Immunol., May 15, 1998; 160(10): 4988 - 4993. [Abstract] [Full Text] [PDF]